Ubs Group Ag Medi Wound Ltd. Transaction History

Ubs Group Ag

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.34 - $4.63 $9,108 - $12,626	-2,727 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$3.38 - $5.71 $6,411 - $10,831	1,897 Added 228.55%	2,727 $10,000
Q1 2021 May 12, 2021	BUY	$3.77 - $6.05 $3,129 - $5,021	830 New	830 $4,000
Q4 2020 Feb 11, 2021	SELL	$3.12 - $4.08 $17,160 - $22,440	-5,500 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$3.09 - $4.14 $5,580 - $7,476	-1,806 Reduced 24.72%	5,500 $21,000
Q2 2020 Jul 31, 2020	BUY	$1.47 - $2.97 $2,654 - $5,363	1,806 Added 32.84%	7,306 $21,000
Q1 2020 May 01, 2020	SELL	$1.57 - $3.1 $6,383 - $12,604	-4,066 Reduced 42.5%	5,500 $9,000
Q4 2019 Feb 14, 2020	BUY	$2.72 - $3.15 $17,440 - $20,197	6,412 Added 203.3%	9,566 $30,000
Q3 2019 Nov 14, 2019	BUY	$2.58 - $3.97 $1,524 - $2,346	591 Added 23.06%	3,154 $10,000
Q2 2019 Aug 14, 2019	BUY	$3.0 - $5.5 $5,448 - $9,988	1,816 Added 243.11%	2,563 $9,000
Q1 2019 May 14, 2019	BUY	$4.24 - $5.24 $3,167 - $3,914	747 New	747 $4,000
Q1 2018 May 15, 2018	SELL	$3.9 - $5.5 $5,885 - $8,299	-1,509 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$4.25 - $5.2 $5,457 - $6,676	1,284 Added 570.67%	1,509 $7,000
Q3 2017 Nov 14, 2017	SELL	$4.8 - $6.95 $6,144 - $8,896	-1,280 Reduced 85.05%	225 $1,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,505	1,505 $11,000

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $686M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.